Begelomab (Anti-DPP4 / CD26)

Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2517
Sku # A2517-1mg*25
Pricing 1mg*25, $5070.00
Feedback